95 filings
Page 4 of 5
6-K
0v2b l02qy4ftdy1ko
17 May 22
Current report (foreign)
4:11pm
S-8
na67gu
26 Apr 22
Registration of securities for employees
4:58pm
20-F
sq3d0cpovy kdgxprz26
26 Apr 22
Annual report (foreign)
4:11pm
6-K
y4qxhad2
26 Apr 22
Provides Corporate Update
4:06pm
6-K
lhrh8n 20r
7 Feb 22
Current report (foreign)
8:10am
6-K
n4ncd
4 Jan 22
Current report (foreign)
9:28am
6-K
03ox sx43j
9 Dec 21
Current report (foreign)
9:11am
6-K
fi0ml mg9wt8n04j61
22 Nov 21
Current report (foreign)
9:21am
6-K
7cfocf9278ut2kl 7m
8 Nov 21
Current report (foreign)
8:01am
6-K
3um6itz
28 Oct 21
Current report (foreign)
4:16pm
6-K
tewv84d
28 Oct 21
Ambrx Biopharma Inc. Reports 1H 2021 Financial Results and Provides Corporate Update
4:11pm
6-K
m414rr
4 Oct 21
Current report (foreign)
8:10am
6-K
t2srx1577z0h47e2z1pn
2 Jul 21
Current report (foreign)
4:15pm
S-8
q5jfnnt06hy27
22 Jun 21
Registration of securities for employees
6:08am
424B4
judpqlj6wkb kigyyd
21 Jun 21
Prospectus supplement with pricing info
6:15am
EFFECT
cnpekt a7lwdtm
18 Jun 21
Notice of effectiveness
12:15am
EFFECT
h90y2
18 Jun 21
Notice of effectiveness
12:15am
SEC STAFF
wek9haxyafm4n 759j0m
17 Jun 21
SEC staff action: Order
12:00am
CERT
utltl75xq
16 Jun 21
Certification of approval for exchange listing
9:56am
8-A12B
k64b 9d6z
15 Jun 21
Registration of securities on exchange
1:34pm